MIMS® Retrospective Chart Review

Sanoculis

Status: Not yet enrolling

Conditions: Open Angle Glaucoma

Treatments: Device: Minimally Invasive Micro Sclerostomy

Study type: Observational

Funder types: Industry

Identifiers

NCT06614218

MMS-EEU-9

Details and patient eligibility

About

This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.

Enrollment: 40 estimated patients

Sex: All

Ages: 40 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Eye treated with MIMS® Device as a standalone procedure
2. MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024

Trial design

40 participants in 1 patient group

MIMS Surgery Cohort

Description:

This cohort consists subjects treated with MIMS® Device as a standalone procedure during time period (27 Sep 2023 - 31 May 2025), and with documented post-operative follow-up available in the medical charts.

Treatment:

Device: Minimally Invasive Micro Sclerostomy